You are here: Industry Insights > Merck

News List

Merck increases measles vaccine production amid outbreak in US pharmaceutical-technology
May 05, 2019
Merck Sharp & Dohme (MSD) has increased the production of its measles vaccine in the US to meet a rise in demand following an outbreak.
Merck’s Keytruda gets FDA approval to treat kidney cancer pharmaceutical-technology
April 24, 2019
Merck has received US Food and Drug Administration (FDA) approval for its anti-PD-1 therapy Keytruda to treat advanced renal cell carcinoma (RCC) patients.
FDA approves Merck's Keytruda in combination with Inlyta biospectrumasia
April 23, 2019
Merck has announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck’s anti-PD-1 therapy……
China’s NMPA approves Novartis’ Cosentyx and Merck’s Keytruda pharmaceutical-technology
April 23, 2019
Novartis has announced that the Chinese National Medical Product Administration (NMPA) has approved its plaque psoriasis drug Cosentyx (secukinumab).
Merck launches drug compound to treat and prevent Folate deficiencies biospectrumasia
April 21, 2019
Merck has launched a new and improved proprietary product: Arcofolin™ L-Methylfolate, a monosodium salt of L-5-methyltetrahydrofolic acid for nutritional and pharmaceutical applications.
FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC drugs
April 18, 2019
FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC.
Merck elevates its BioContinuum platform strategy to deliver ‘ContiGuous’ bioprocessing europeanpharmaceuticalreview
April 12, 2019
Launch is taking place at the International Pharmaceutical Expo (INTERPHEX) in New York...
Merck recognised with INTERPHEX Exhibitor Award for Best New Product europeanpharmaceuticalreview
April 12, 2019
Merck wins award for first-of-its-kind, single-use tangential flow filtration capsule used in ADC and monoclonal antibody bioprocessing…
FDA expands first-line NSCLC label for Merck & Co.'s Keytruda firstwordpharma
April 12, 2019
FDA expands first-line NSCLC label for Merck & Co.'s Keytruda.
Kymab announces Merck exec Simon Sturge as new CEO pharmafile
April 11, 2019
Kymab announces Merck exec Simon Sturge as new CEO.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page